Ledger.Open graph →
SEC Form D · filed January 12, 2021

NeuroBo Pharmaceuticals, Inc

Offering
$17.0M
Sold
$17.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Richard J. Kang · Boston, MAExec · DirectorJason J. Groves · Boston, MADirectorAkash J. Bakshi · Boston, MAExec · DirectorJeong Gyun J. Oh · Boston, MADirectorMichael J. Salsbury · Boston, MADirectorYeon J. Kim · Boston, MADirectorNicola J. Shannon · Boston, MAExecDouglas J. Swirsky · Boston, MADirectorMichael Gaubert · Dallas, TXDirectorDerek Dunlop · Dallas, TXDirectorDeborah D. Flickinger · Los Angeles, CADirectorJeffrey Baird · Oakland, CAExecPatrick Sakala · George Town, Cayman IslandsExec · DirectorItay Goren · Wilmington, DEDirectorMichael J. Salsbury · Boston, MADirectorJoshua J. Widoff · Denver, COExec · DirectorAndrew J. Bartynski · Boston, MAExecNadja J. Mannowetz · Boston, MAExecJohn Monteiro · Dallas, TXDirectorCharlie Yue · Dallas, TXDirectorBrad Perry · Dallas, TXDirectorWilliam Hancock · DALLAS, TXDirectorPriya Kashyap · Dallas, TXExecVictor Whitmore · Tulsa, OKExec · DirectorThomas Cahill · Miami, FLExec · DirectorMelissa Bethell · London, United KingdomDirectorAndrew J. Bartynski · Boston, MAExecNadja J. Mannowetz · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗